CY2446B1 - Phthalazinones. - Google Patents

Phthalazinones.

Info

Publication number
CY2446B1
CY2446B1 CY0400064A CY0400064A CY2446B1 CY 2446 B1 CY2446 B1 CY 2446B1 CY 0400064 A CY0400064 A CY 0400064A CY 0400064 A CY0400064 A CY 0400064A CY 2446 B1 CY2446 B1 CY 2446B1
Authority
CY
Cyprus
Prior art keywords
pct
date jul
sec
pub
phthalazinones
Prior art date
Application number
CY0400064A
Other languages
English (en)
Inventor
Van Der Margaretha Mey
Van Der Ivonne Johanna Laan
Hendrik Timmerman
Armin Hatzelmann
Hildegard Boss
Dietrich Haefner
Rolf Beume
Hans-Peter Kley
Geert Jan Sterk
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2446B1 publication Critical patent/CY2446B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Lubricants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CY0400064A 1997-01-15 2004-08-11 Phthalazinones. CY2446B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97100488 1997-01-15

Publications (1)

Publication Number Publication Date
CY2446B1 true CY2446B1 (en) 2004-11-12

Family

ID=8226366

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400064A CY2446B1 (en) 1997-01-15 2004-08-11 Phthalazinones.

Country Status (26)

Country Link
US (1) US6103718A (cs)
EP (1) EP0971901B1 (cs)
JP (1) JP2001508078A (cs)
KR (1) KR20000070150A (cs)
CN (1) CN1127487C (cs)
AT (1) ATE233247T1 (cs)
AU (1) AU735934B2 (cs)
BR (1) BR9806752A (cs)
CA (1) CA2276455C (cs)
CY (1) CY2446B1 (cs)
CZ (1) CZ293815B6 (cs)
DE (1) DE69811645T2 (cs)
DK (1) DK0971901T3 (cs)
EA (1) EA002764B1 (cs)
EE (1) EE03968B1 (cs)
ES (1) ES2193508T3 (cs)
HU (1) HUP0001541A3 (cs)
IL (1) IL130659A (cs)
NO (1) NO313137B1 (cs)
NZ (1) NZ336573A (cs)
PL (1) PL189418B1 (cs)
PT (1) PT971901E (cs)
SI (1) SI0971901T1 (cs)
SK (1) SK283270B6 (cs)
TR (1) TR199901653T2 (cs)
WO (1) WO1998031674A1 (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
CA2323771A1 (en) * 1998-03-14 1999-09-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone pde iii/iv inhibitors
WO2001019818A1 (en) * 1999-09-14 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone derivatives as pd3/4 inhibitors
CN1146562C (zh) * 1999-10-25 2004-04-21 奥坦纳医药公司 作为pde4抑制剂的四氢噻喃2,3-二氮杂萘酮类衍生物
US6756371B1 (en) 1999-10-25 2004-06-29 Altana Pharma Ag Phthalazinone derivatives as PDE4 inhibitors
PL358057A1 (en) * 2000-06-05 2004-08-09 Altana Pharma Ag Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
US20040224316A1 (en) * 2000-08-10 2004-11-11 Tully Timothy P. Augmented cognitive training
US7868015B2 (en) * 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
BR0207278A (pt) 2001-02-15 2004-02-10 Altana Pharma Ag Derivados de ftalazinona-piperidina como inibidores de pde4
CA2445236A1 (en) * 2001-04-25 2002-10-31 Altana Pharma Ag Piperazino-derivatives and their use as pde4 inhibitor
KR20040008162A (ko) * 2001-04-25 2004-01-28 알타나 파마 아게 신규한 프탈라지논
RU2292337C2 (ru) 2002-02-19 2007-01-27 Оно Фармасьютикал Ко., Лтд. Конденсированные производные пиридазина и лекарственные препараты, содержащие данные соединения в качестве активного ингредиента
WO2004018451A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Pyridazinone-derivatives as pde4 inhibitors
JP4555684B2 (ja) 2002-08-10 2010-10-06 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Pde4阻害剤としての、ピロリジンジオンにより置換されたピペリジン−フタラゾン
WO2004018449A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
JP2005538137A (ja) * 2002-08-10 2005-12-15 アルタナ ファルマ アクチエンゲゼルシャフト ピペリジン−n−オキシド誘導体
WO2004087211A2 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
WO2004098633A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Composition comprising a pde-4 inhibitor and a tnf alpha antagonist
CN1823051B (zh) 2003-07-14 2010-07-07 宇部兴产株式会社 4-氨基四氢吡喃化合物及其酸盐的制造方法、其合成中间体及其制造方法
US20080227790A1 (en) * 2004-02-04 2008-09-18 Altana Pharma Ag Pyridazinone Derivatives and their Use as Pde4 Inhibitors
CA2554797C (en) * 2004-02-04 2012-09-04 Altana Pharma Ag 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
EP1873147A4 (en) * 2005-04-21 2010-01-06 Nippon Shinyaku Co Ltd PHTHALAZINON DERIVATIVE AND THEREOF PHARMACEUTICALS
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
HRP20110940T1 (hr) 2007-05-16 2012-01-31 Nycomed Gmbh Derivati pirazolona kao inhibitori pde4
AR074318A1 (es) 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EA023713B1 (ru) * 2011-06-17 2016-07-29 Такеда Гмбх Производные фталазинонпирролопиримидинкарбоксамида
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
HK1220610A1 (zh) 2013-03-13 2017-05-12 弗拉特利发现实验室有限责任公司 哒嗪酮化合物和用於治疗囊肿状纤维化的方法
US20150050626A1 (en) * 2013-03-15 2015-02-19 Dart Neuroscience, Llc Systems, Methods, and Software for Improving Cognitive and Motor Abilities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
NZ257955A (en) * 1992-12-02 1996-05-28 Pfizer Catechol diethers pharmaceutical compositions
EP0634404A1 (en) * 1993-07-13 1995-01-18 Rhone Poulenc Agriculture Ltd. Phtalazin derivatives and their use as pesticides
CA2173493C (en) * 1994-08-09 2008-03-25 Nobuhisa Watanabe Fused pyridazine compounds

Also Published As

Publication number Publication date
CZ293815B6 (cs) 2004-08-18
WO1998031674A1 (en) 1998-07-23
KR20000070150A (ko) 2000-11-25
HK1024692A1 (en) 2000-10-20
CN1249749A (zh) 2000-04-05
HUP0001541A2 (hu) 2001-05-28
DE69811645D1 (de) 2003-04-03
CN1127487C (zh) 2003-11-12
SK283270B6 (sk) 2003-04-01
US6103718A (en) 2000-08-15
PL334561A1 (en) 2000-03-13
DE69811645T2 (de) 2003-12-04
IL130659A (en) 2002-07-25
TR199901653T2 (xx) 1999-10-21
HUP0001541A3 (en) 2001-11-28
EP0971901A1 (en) 2000-01-19
CA2276455A1 (en) 1998-07-23
EE03968B1 (et) 2003-02-17
NZ336573A (en) 2000-10-27
ES2193508T3 (es) 2003-11-01
CA2276455C (en) 2006-10-31
CZ253399A3 (cs) 2000-05-17
EA199900620A1 (ru) 2000-04-24
IL130659A0 (en) 2000-06-01
BR9806752A (pt) 2000-03-14
NO993301D0 (no) 1999-07-02
SK95199A3 (en) 1999-12-10
PT971901E (pt) 2003-07-31
DK0971901T3 (da) 2003-06-10
NO313137B1 (no) 2002-08-19
EE9900274A (et) 2000-02-15
PL189418B1 (pl) 2005-08-31
SI0971901T1 (en) 2003-10-31
JP2001508078A (ja) 2001-06-19
NO993301L (no) 1999-09-10
AU5862998A (en) 1998-08-07
EP0971901B1 (en) 2003-02-26
ATE233247T1 (de) 2003-03-15
AU735934B2 (en) 2001-07-19
EA002764B1 (ru) 2002-08-29

Similar Documents

Publication Publication Date Title
CY2446B1 (en) Phthalazinones.
SI1070056T1 (en) Phthalazinone pde iii/iv inhibitors
DE69809754D1 (en) Substituierte 6-phenylphenanthridine
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
IL129054A0 (en) Benzonaphthyridines as bronchial therapeutics
BG105561A (en) Phenylphenanthridines with pde-iv inhibiting activity
BR9811956A (pt) Naftiridinonas para a inibição de proteìna tirosina cinase e de proliferação celular mediada por cinase de ciclo de célula
SI0998460T1 (en) Novel tetrazole derivatives
MY135909A (en) Treatment of pulmonary hypertension
PT941221E (pt) Dihidrobenzofuranos substituidos como inibidores de fosfodiesterase (pde)
DK0920426T3 (da) Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning
MXPA02012470A (es) Inhibidores de fosfodiesterasa especificos para gmp ciclico.
SI1377574T1 (cs)